Results 71 to 80 of about 743 (164)

Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis

open access: yesBMC Health Services Research, 2018
Background Our primary aim was to assess the ability of a non-profit foundation-sponsored clinic network to facilitate access to specialized care for patients with neurofibromatoses (NF), a group of neurogenetic disorders including NF1, NF2, and ...
Vanessa L. Merker   +5 more
doaj   +1 more source

Oral Levodopa Therapy, Vitamin B6 and Peripheral Neuropathy: A Cross‐Sectional Observational Study

open access: yes
Movement Disorders Clinical Practice, Volume 12, Issue 1, Page 120-122, January 2025.
Catherine Déry   +7 more
wiley   +1 more source

Gonadal and gonadosomatic mosaicism in NF1: report of two families

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 3, Page 426-428, March 2024.
Magdalena Seidl‐Philipp   +10 more
wiley   +1 more source

Gonadales und gonadosomatisches Neurofibromatose‐Typ‐1‐Mosaik: ein Bericht über zwei Familien

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 3, Page 426-429, March 2024.
Magdalena Seidl‐Philipp   +10 more
wiley   +1 more source

The neurofibromatoses: when less is more [PDF]

open access: yesHuman Molecular Genetics, 2001
The study of cancer predisposition syndromes presents unique opportunities to gain insights into the genetic events associated with tumor pathogenesis. Individuals with two inherited cancer syndromes, neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2), develop both benign and malignant tumors. The corresponding genes mutated in these two disorders
openaire   +2 more sources

Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France

open access: yesOrphanet Journal of Rare Diseases, 2011
Background Neurofibromatosis 1 (NF1), a common autosomal dominant disorder, was shown in one study to be associated with a 15-year decrease in life expectancy. However, data on mortality in NF1 are limited.
Hadj-Rabia Smaïl   +12 more
doaj   +1 more source

Neurofibromatosis: chronological history and current issues Neurofibromatose: histórico cronológico e aspectos atuais

open access: yesAnais Brasileiros de Dermatologia, 2013
Neurofibromatosis, which was first described in 1882 by Von Recklinghausen, is a genetic disease characterized by a neuroectodermal abnormality and by clinical manifestations of systemic and progressive involvement which mainly affect the skin, nervous ...
João Roberto Antônio   +2 more
doaj  

Utilização da tração halo-craniana pré-operatória no tratamento de deformidades vertebrais de alto valor angular Uso de tracción halo gravitacional en el tratamiento quirúrgico de las deformidades graves de la columna vertebral Halo gravity preoperative traction in severe spine deformities treatment

open access: yesColuna/Columna, 2010
OBJETIVOS: avaliar o resultado do tratamento cirúrgico das deformidades acentuadas da coluna vertebral por meio da utilização da tração halo-gravitacional.
Maximiliano Aguiar Porto   +3 more
doaj   +1 more source

Schwannomas in the head and neck: retrospective analysis of 21 patients and review of the literature

open access: yesSão Paulo Medical Journal
CONTEXT AND OBJECTIVE: Schwannomas are benign neoplasms of the peripheral nerves originating in the Schwann cells. According to their cellularity, they can be subdivided into Antoni A or Antoni B types.
Erwin Langner   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy